Royce Laboratories, Inc. v. Bristol-Myers Squibb Co.

516 U.S. 1026, 116 S. Ct. 670, 133 L. Ed. 2d 520, 64 U.S.L.W. 3416, 1995 U.S. LEXIS 8586
CourtSupreme Court of the United States
DecidedDecember 11, 1995
DocketNo. 95-737
StatusPublished

This text of 516 U.S. 1026 (Royce Laboratories, Inc. v. Bristol-Myers Squibb Co.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Royce Laboratories, Inc. v. Bristol-Myers Squibb Co., 516 U.S. 1026, 116 S. Ct. 670, 133 L. Ed. 2d 520, 64 U.S.L.W. 3416, 1995 U.S. LEXIS 8586 (1995).

Opinion

C. A. Fed. Cir. Motion of petitioner to expedite consideration of petition for writ of certiorari denied.

Jus[1027]*1027tice O’Connor took no part in the consideration or decision of this motion.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
516 U.S. 1026, 116 S. Ct. 670, 133 L. Ed. 2d 520, 64 U.S.L.W. 3416, 1995 U.S. LEXIS 8586, Counsel Stack Legal Research, https://law.counselstack.com/opinion/royce-laboratories-inc-v-bristol-myers-squibb-co-scotus-1995.